Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study will provide an initial assessment of the safety, tolerability, and
pharmacokinetics (PK) of PAZ-417 after administration of ascending single oral doses to
healthy young Japanese male and healthy elderly Japanese male subjects.